Keywords: receptagen, develops, iv, coq10, formulation, completed, feasibility

Receptagen Develops IV CoQ10 Formulation

Article | 21 November 1994

Print This

Receptagen has completed feasibility studies of an intravenous form of coenzyme Q10, its agent for the prevention of programmed cell ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in